Cambridge Investment Research Advisors
CANC icon

Cambridge Investment Research Advisors’s Tema Oncology ETF CANC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Buy
+5,335
New +$202K ﹤0.01% 3473

Other funds holding CANC

RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

Cambridge Investment Research Advisors's CANC Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Tema Oncology ETF (CANC) in Q2 2026: 5,335 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #3473 among its holdings.

2 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,335 shares of Tema Oncology ETF worth $220K as of Q2 2026.
  • Tema Oncology ETF was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Tema Oncology ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3473 holding.
  • 2 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.